FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 268 filers reported holding FATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,000 | -57.7% | 15,971 | -1.2% | 0.00% | – |
| Q2 2023 | $78,000 | -17.0% | 16,171 | -2.9% | 0.00% | – |
| Q1 2023 | $94,000 | -40.9% | 16,656 | +5.6% | 0.00% | – |
| Q4 2022 | $159,000 | -59.3% | 15,775 | -9.7% | 0.00% | -100.0% |
| Q3 2022 | $391,000 | +49.8% | 17,469 | +67.2% | 0.00% | 0.0% |
| Q2 2022 | $261,000 | -63.4% | 10,450 | -43.1% | 0.00% | -50.0% |
| Q1 2022 | $714,000 | -29.9% | 18,361 | +5.9% | 0.00% | 0.0% |
| Q4 2021 | $1,019,000 | +30.8% | 17,345 | +31.8% | 0.00% | 0.0% |
| Q3 2021 | $779,000 | -34.4% | 13,163 | -5.6% | 0.00% | -33.3% |
| Q2 2021 | $1,188,000 | +118.8% | 13,950 | +112.9% | 0.00% | +50.0% |
| Q1 2021 | $543,000 | – | 6,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |